Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Sarcoma 1Dermatologic 1CNS 1

Conditions

Melanoma 2Sarcoma 1Melanoma, Cutaneous Malignant 1Hematologic Neoplasms 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 3trametinib 2pertuzumab 2dabrafenib 2Trastuzumab 2Tacrolimus 2Specimen Handling 2Polymerase Chain Reaction 2Nivolumab 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1tinostamustine 1temsirolimus 1sonidegib 1selinexor 1sapanisertib 1romidepsin 1relatlimab 1palbociclib 1osimertinib 1omipalisib 1merphos 1larotrectinib 1ipatasertib 1fludarabine phosphate 1erdafitinib 1entrectinib 1defactinib 1copanlisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Genetic Testing × Dermatologic × Clear all
NCT01772771 2026-03-03

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

M.D. Anderson Cancer Center

Recruiting
12,000 enrolled
CNSDermatologicOther hematologic neoplasmSarcoma

Glioma, Melanoma, Sarcoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡